生物可吸收支架市場規模、佔有率及成長分析（按材料類型、應用、最終用戶和地區）- 2025-2032 年產業預測

生物可吸收支架市場規模預計在 2023 年達到 17.1 億美元，並從 2024 年的 20.4 億美元成長到 2032 年的 85 億美元，預測期內（2025-2032 年）的複合年成長率為 19.5%。

由於技術進步和心血管疾病發病率上升，生物可吸收支架市場正在經歷強勁成長。這些臨時植入旨在透過逐漸溶解，使血管自然癒合來治療冠狀動脈疾病。聚合物材料由於其高生物相容性而佔據該市場的主導地位，主要用於心血管護理等多種應用。最終用戶包括醫院、門診手術中心和專科診所，這是由心臟病住院人數的增加所推動的。從地區來看，擁有先進醫療體系的北美佔據最大市場佔有率，其次是以研究為重點的歐洲，以及受醫療投資和人口老化推動的亞太地區。儘管存在成本和對熟練專業人員的需求等挑戰，正在進行的研究表明未來市場成長前景看好。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

生物可吸收支架市場規模（依材料類型和複合年成長率） (2025-2032)

• 市場概況
• 聚合物支架
• 金屬鷹架

生物可吸收支架市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 冠狀動脈疾病
• 周邊動脈疾病

生物可吸收支架市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 門診手術中心
• 心導管實驗室

生物可吸收支架市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Terumo Corporation（Japan）
• Biotronik SE & Co. KG（Germany）
• REVA Medical, Inc.（USA）
• Elixir Medical Corporation（USA）
• Amaranth Medical, Inc.（USA）
• Arterial Remodeling Technologies（France）
• Meril Life Sciences Pvt. Ltd.（India）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• S3V Vascular Technologies（India）
• Zorion Medical（USA）
• ICON Interventional Systems（USA）
• Xenogenics Corporation（USA）
• Arterius Limited（UK）
• SMT（Sahajanand Medical Technologies）（India）
• B. Braun Melsungen AG（Germany）
• Cardionovum GmbH（Germany）

結論和建議

Bioresorbable Scaffolds Market size was valued at USD 1.71 billion in 2023 and is poised to grow from USD 2.04 billion in 2024 to USD 8.5 billion by 2032, growing at a CAGR of 19.5% during the forecast period (2025-2032).

The bioresorbable scaffolds market is experiencing robust growth propelled by technological advancements and a rising prevalence of cardiovascular diseases. These temporary implants, designed to treat coronary artery disease by gradually dissolving, allow for natural vessel healing. Dominated by polymer-based materials due to their biocompatibility, the market also addresses diverse applications, predominantly in cardiovascular treatment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, driven by increased cardiac intervention admissions. Geographically, North America leads in market share, supported by advanced healthcare systems, followed by Europe with its research focus, and a growing Asia-Pacific region due to healthcare investments and an aging demographic. Despite challenges like costs and the need for skilled professionals, ongoing research suggests promising market expansion ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, significantly propels the growth of the bioresorbable scaffolds market. As these health issues become more prevalent, there is an increasing need for advanced therapeutic options that can effectively restore blood flow. This situation fosters a strong demand for innovative medical solutions, such as bioresorbable scaffolds, which offer unique advantages in the treatment of vascular conditions. The ability of these scaffolds to provide temporary support to blood vessels while gradually dissolving is particularly appealing to healthcare providers looking to improve patient outcomes, further driving market expansion.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is confronted with a significant obstacle due to the shortage of long-term clinical evidence. There remains a pressing need for comprehensive evaluations of the performance of bioresorbable scaffold implants in comparison to conventional stents. This lack of conclusive data on their efficacy and safety could hinder healthcare professionals from fully embracing these innovative solutions, potentially affecting adoption rates. As a result, the industry must prioritize the generation of robust clinical studies to substantiate the long-term benefits and reliability of bioresorbable scaffolds, ensuring that they can be confidently integrated into patient care practices.

Market Trends of the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market is experiencing a notable surge, primarily driven by the rising geriatric population, which necessitates enhanced healthcare solutions. As the elderly demographic becomes more predominant, their susceptibility to cardiovascular diseases escalates, creating a substantial demand for innovative treatment options. Bioresorbable scaffolds offer a compelling alternative due to their ability to support vascular structures temporarily and then dissolve, eliminating the need for additional surgical interventions. This trend indicates a shift towards patient-centric approaches in cardiology, with healthcare providers increasingly adopting biocompatible materials to improve patient outcomes and overall quality of life in an aging society.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Polymer-based Scaffolds
• Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2025-2032)

• North America (Material Type, Application, End-user)
  • US
  • Canada
• Europe (Material Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S3V Vascular Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zorion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenogenics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT (Sahajanand Medical Technologies) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations